Febuxostat acquires the 13th exclusive sale product right

Published: 2015-12-15 14:14:38

Updated: 2015-12-15 14:14:38

‘Febuxostat,’ which has been prohibited to sell due to the lawsuit winning of generic companies, was registered as the 13^th exclusive sales pharmaceutical product.

The Ministry of Food and Drug Safety(MFDS) announced approval of ‘Febuxostat Film 40~80mg’ as exclusive sales pharmaceutical products from the 11^th.

Febuxostat is a chronic hyperuricemia treatment of gout patients, introduced by SK...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.